China Health Group Ltd operates within the Medical and hospital equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Health Group Ltd with three other
miscellaneous wholesalers in Asia:
sales of 1.36 billion Japanese Yen [US$12.33 million]
of which 84%
was B to B Business),
Uni Pharma Co Ltd
(138.64 million Taiwanese Dollars [US$4.99 million]
Grand Brilliance Group Holdings Ltd
(67.23 million Hong Kong Dollars [US$8.66 million]
of which 73%
was Medical consumables).
Sales were up sharply during the second
quarter of 2021 versus the previous year's second quarter.
During the second
quarter of 2021, sales at China Health Group Ltd totalled
an increase of 60.1%
from the HK$20.87 million in sales at the company during the second quarter of 2020.
During the year ended March of 2020, sales at
China Health Group Ltd were HK$45.16 million (US$5.82 million).
increase of 40.3%
versus 2019, when the company's sales were HK$32.18 million.
This was the third consecutive year of growth at China Health Group Ltd.
Sales of Trading of Medical Equipment saw an increase
75.2% in 2020, from
HK$16.93 million to HK$29.65 million.
Not all segments of China Health Group Ltd experienced an increase in sales in 2020:
sales of Property Investment fell 37.4% to HK$732,000.00 .
(However, this segment's sales were only a very small portion of the company's overall sales).
China Health Group Ltd also experienced decreases in sales in
Business Factoring (down 12.7% to HK$3.67 million)